Alignment Healthcare Inc
3 nominees · 3 ballot items.
Election of three Class II directors; ratification of Deloitte & Touche LLP as independent registered public accounting firm for 2026; and a non-binding, advisory approval of the compensation of the company’s named executive officers (say-on-pay).
Follow how the vote landed and what changed on Alignment Healthcare Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect three Class II director nominees (Jody Bilney, David Hodgson, Jacqueline Kosecoff) to hold office until the 2029 Annual Meeting.
- 2
Ratification of Appointment of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify the Audit Committee’s appointment of Deloitte & Touche LLP as Alignment’s independent registered public accounting firm for the year ending December 31, 2026.
- 3
Non-Binding, Advisory Vote on Executive Compensation (Say-on-Pay
ManagementBoard: FORAdvisory approval of the compensation of the Company’s Named Executive Officers as disclosed in the proxy statement (a non-binding 'say-on-pay' vote).
More detail
This non-binding advisory proposal asks stockholders to approve the compensation paid to Alignment’s Named Executive Officers (NEOs) as disclosed in the proxy statement. Management frames the program as pay-for-performance with a significant portion of NEO pay delivered through performance-based incentives and long-term equity to align executives with stockholder value creation. The Compensation Committee uses market peer data and an independent consultant to set target pay, applies annual cash incentives tied to membership growth, adjusted gross profit and adjusted EBITDA less capex, and applies a CMS Stars modifier to emphasize quality of care. Long-term incentives are 50% RSUs (time-based retention) and 50% PSUs tied to multi-year revenue and adjusted EBITDA targets, with PSUs earned from 0% to 200% of target and multi-year vesting to promote sustained performance. The Board’s recommendation to vote FOR cites strong governance: independent committee oversight, a clawback policy, stock ownership guidelines, and an emphasis on variable, at-risk compensation rather than fixed pay. Because the vote is advisory, approval does not change compensation contracts but signals stockholder support; the Board and Compensation Committee commit to consider the vote outcome when setting future pay. Contextually, Alignment reported strong 2025 operational results (membership growth, revenue growth, improved adjusted EBITDA) that management says justify the compensation outcomes; however, investors will assess whether pay outcomes align with long-term value given prior large equity awards and realized pay volatility. The existence of CMS Star-related adjustments and multi-year PSU metrics ties near-term pay to member outcomes and longer-term financial targets, which management argues mitigates short-termism; opponents could still critique quantum or realized payouts. In sum, the proposal asks for an endorsement of a compensation framework designed to link pay to operational and financial performance, and the Board recommends approval based on governance practices and pay-for-performance design.
Nominees on the ballot3
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | WELLINGTON MANAGEMENT GROUP LLP | 7.0% | 14,521,298 | $256M |
| 2 | T. Rowe Price Investment Management, Inc. | 6.4% | 13,147,656 | $232M |
| 3 | FMR LLC | 6.0% | 12,439,241 | $219M |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.7% | 9,710,071 | $171M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 7,973,663 | $140M |
| 6 | BlackRock, Inc. | 3.4% | 7,102,922 | $125M |
| 7 | Invesco Ltd. | 2.9% | 6,093,507 | $107M |
| 8 | Hood River Capital Management LLC | 2.9% | 6,054,477 | $107M |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.7% | 5,527,603 | $97M |
| 10 | CITADEL ADVISORS LLC | 2.6% | 5,362,666 | $94M |
Other Healthcare sector meetings6
Upcoming shareholder meetings at Alignment Healthcare Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Alignment Healthcare Inc 2026 annual meeting?
- Alignment Healthcare Inc (ALHC) holds its 2026 annual shareholder meeting on Thursday, June 4, 2026.
- What is the record date for the Alignment Healthcare Inc 2026 meeting?
- The record date for the Alignment Healthcare Inc 2026 meeting is Monday, April 6, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Alignment Healthcare Inc's 2026 meeting?
- The board is presenting 3 director nominees at the Alignment Healthcare Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Alignment Healthcare Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Alignment Healthcare Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.